StocktoriaEXICURE, INC. XCUR
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $0 | $500,000 | $0 | $28.8M | -$483,000 |
| Operating income | -$4.2M | -$12.2M | -$15.0M | -$1.8M | -$62.5M |
| Net income | -$4.9M | -$9.7M | -$16.9M | -$2.6M | -$64.1M |
| Operating cash flow | -$8.6M | -$2.9M | -$10.4M | -$35.7M | -$34.8M |
| Free cash flow | -$8.6M | -$2.9M | -$10.4M | -$35.7M | -$35.8M |
| Total assets | $14.0M | $15.1M | $11.6M | $23.3M | $64.9M |
| Total liabilities | $10.1M | $8.3M | $8.5M | $8.4M | $53.6M |
| Shareholders' equity | $3.9M | $6.8M | $3.0M | $14.9M | $11.2M |
| Ratios | |||||
| Operating margin | — | -2446.4% | — | -6.4% | 12950.1% |
| Net margin | — | -1940.2% | — | -9.0% | 13271.6% |
| FCF margin | — | -582.0% | — | -123.7% | 7409.3% |
| Return on assets | -35.2% | -64.4% | -146.1% | -11.1% | -98.8% |
| Return on equity | -126.0% | -143.3% | -558.0% | -17.3% | -570.7% |
| Debt / equity | — | — | — | — | 0.61× |
| Current ratio | 1.19 | 4.45 | 0.81 | 6.13 | 1.28 |
| Revenue growth | -100.0% | — | -100.0% | -6068.1% | -102.9% |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001698530 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.